Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name JQ1
Trade Name
Synonyms JQ-1
Drug Descriptions

JQ1 is a BET bromodomain inhibitor with greatest specificity towards BRD4, resulting in decreased Myc expression, increased cell death, reduced macrophage immunosuppression, and inhibition of tumor growth (PMID: 24231268, PMID: 31018997, PMID: 30906568, PMID: 32800944).

DrugClasses BET Inhibitor (Pan) 32
CAS Registry Number 1268524-70-4
NCIT ID NA

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
A-485 + JQ1 A-485 JQ1 0 0
Arsenic trioxide + Chloroquine + JQ1 Arsenic trioxide Chloroquine JQ1 0 0
Arsenic trioxide + JQ1 Arsenic trioxide JQ1 0 0
BAZ2-ICR + BI-9564 + JQ1 BAZ2-ICR BI-9564 JQ1 0 0
BAZ2-ICR + JQ1 BAZ2-ICR JQ1 0 0
Carboplatin + JQ1 Carboplatin JQ1 0 0
Cisplatin + JQ1 Cisplatin JQ1 0 0
Crizotinib + JQ1 Crizotinib JQ1 0 0
Dasatinib + JQ1 Dasatinib JQ1 0 0
Docetaxel + JQ1 Docetaxel JQ1 0 0
Gemcitabine + JQ1 Gemcitabine JQ1 0 0
GSK2801 + JQ1 GSK2801 JQ1 0 0
HY-16462 + JQ1 HY-16462 JQ1 0 0
I-CBP112 + JQ1 I-CBP112 JQ1 1 0
Ixazomib + JQ1 Ixazomib JQ1 0 0
JQ1 JQ1 7 0
JQ1 + MRK-003 JQ1 MRK-003 0 0
JQ1 + Osimertinib JQ1 Osimertinib 0 0
JQ1 + Paclitaxel JQ1 Paclitaxel 0 0
JQ1 + Paclitaxel + unspecified PD-L1 antibody JQ1 Paclitaxel unspecified PD-L1 antibody 0 0
JQ1 + Palbociclib JQ1 Palbociclib 0 0
JQ1 + Panobinostat JQ1 Panobinostat 0 0
JQ1 + PF-3758309 JQ1 PF-3758309 0 0
JQ1 + PLX8394 JQ1 PLX8394 1 0
JQ1 + Ribociclib JQ1 Ribociclib 0 0
JQ1 + Rucaparib JQ1 Rucaparib 0 0
JQ1 + SCH772984 JQ1 SCH772984 0 0
JQ1 + Silmitasertib JQ1 Silmitasertib 0 0
JQ1 + Trametinib JQ1 Trametinib 0 0
JQ1 + Ulixertinib JQ1 Ulixertinib 1 0
JQ1 + unspecified PD-L1 antibody JQ1 unspecified PD-L1 antibody 1 0
JQ1 + VE-821 JQ1 VE-821 0 0
JQ1 + Vemurafenib JQ1 Vemurafenib 0 0
JQ1 + Vinorelbine JQ1 Vinorelbine 0 0
JQ1 + XPW1 JQ1 XPW1 0 0
JQ1 + ZW25 JQ1 ZW25 0 0


Additional content available in CKB BOOST